Evidence map›Paper›PMID 28564628›Full record

ArticleJournal of affective disorders2017

Severity of anxiety- but not depression- is associated with oxidative stress in Major Depressive Disorder.

Lisa R Steenkamp, Christina M Hough, Victor I Reus, Felipe A Jain, Elissa S Epel, S Jill James, Alexandra E Morford, Synthia H Mellon, Owen M Wolkowitz, Daniel Lindqvist

Open access · greenAbstract read
In one paragraph

Article in Journal of affective disorders, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. The Relationship between FAntioxidants (Basel, Switzerland) · 2022
    Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Lisa R SteenkampDepartment of Psychiatry, University of California San Francisco (UCSF) School of Medicine, San Francisco, CA, United States; Institute of Psychology, Leiden University, Leiden, The Netherlands.
Christina M HoughDepartment of Psychiatry, University of California San Francisco (UCSF) School of Medicine, San Francisco, CA, United States.
Victor I ReusDepartment of Psychiatry, University of California San Francisco (UCSF) School of Medicine, San Francisco, CA, United States.
Felipe A JainDepartment of Psychiatry, University of California San Francisco (UCSF) School of Medicine, San Francisco, CA, United States.
Elissa S EpelDepartment of Psychiatry, University of California San Francisco (UCSF) School of Medicine, San Francisco, CA, United States.
S Jill JamesArkansas Children's Research Institute, Department of Pediatrics, University of Arkansas for Medical, Sciences, Little Rock, AR, United States.
Alexandra E MorfordDepartment of Psychiatry, University of California San Francisco (UCSF) School of Medicine, San Francisco, CA, United States.
Synthia H MellonDepartment of OB/GYN and Reproductive Sciences, University of California San Francisco (UCSF), School of Medicine, San Francisco, CA, United States.
Owen M WolkowitzDepartment of Psychiatry, University of California San Francisco (UCSF) School of Medicine, San Francisco, CA, United States. Electronic address: Owen.Wolkowitz@ucsf.edu.
Daniel LindqvistDepartment of Psychiatry, University of California San Francisco (UCSF) School of Medicine, San Francisco, CA, United States; Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Psychiatry, Sweden.
University of California, San Francisco · USLund University · SEUniversity of Arkansas for Medical Sciences · US

Funding

UCSF CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR024131 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSTON, S. CLAIBORNE · 2006 to 2011
$111.2M
Cell Aging in Major DepressionR01MH083784 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI EPEL, ELISSA S., MELLON, SYNTHIA H · 2010 to 2020
$6.7M
NCRR NIH HHS UL1 RR024131NIMH NIH HHS R01 MH083784
6 · The paper itself

Abstract

backgroundOxidative stress is implicated in both depression and anxiety, but it is currently unclear whether this relates to syndromal diagnoses or trans-diagnostic dimensional symptoms. We examined the relationship between oxidative stress and severity of depression and anxiety symptoms in individuals with Major Depressive Disorder (MDD).

methodsPlasma oxidative stress markers F2-isoprostanes and oxidized glutathione (GSSG), and the antioxidant reduced glutathione (GSH), were assessed in 69 physically healthy, medication-free MDD subjects. Symptoms of anxiety and depression were assessed using the Hamilton Anxiety (HAM-A) and Hamilton Depression (HAM-D) Rating Scales. Total HAM-A and HAM-D scores, along with "core" anxiety and depression subscales, and individual HAM-D items "psychic anxiety" and "depressed mood," were related to oxidative stress markers. Analyses controlled for age, sex, BMI, and smoking.

resultsTotal HAM-A ratings were positively associated with F2-isoprostanes (β=.26, p=.042) and GSSG (β=.25, p=.049), but not GSH (β=.05, p=.711). Core anxiety severity was positively associated with F2-isoprostanes (β=.34, p=.012) and GSSG, although this did not reach significance (β=.24, p=.074). None of the biological markers were significantly associated with total HAM-D or core depression ratings (all p>.13). Subjects scoring high on "psychic anxiety" had elevated F2-isoprostanes (p=.030) and GSSG (p=.020). This was not seen with "depressed mood" scores (all p>.12). LIMITATIONS: We assessed peripheral oxidative markers, but their relationship to the brain is unclear.

conclusionsOxidative stress is more closely related to anxiety than depression symptoms in MDD. This highlights the importance of relating oxidative stress to specific symptoms and could provide new insights into the biological correlates of affective disorders.

Indexed as

AdultAnxietyBiomarkersDepressionF2-IsoprostanesFemaleGlutathioneGlutathione DisulfideHumansMajor Depressive DisorderMaleMiddle AgedOxidative StressSeverity of Illness IndexBiomarkersF2-IsoprostanesGlutathioneGlutathione DisulfideAnxietyF2-isoprostanesMajor Depressive DisorderOxidative stressOxidized glutathioneReduced glutathione

Identifiers

PMID28564628
PMCPMC5550320
OpenAlexW2610449004

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.